rs10517665

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001083619.3(GRIA2):​c.230-22302G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.196 in 151,922 control chromosomes in the GnomAD database, including 3,350 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.20 ( 3350 hom., cov: 31)

Consequence

GRIA2
NM_001083619.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.462

Publications

3 publications found
Variant links:
Genes affected
GRIA2 (HGNC:4572): (glutamate ionotropic receptor AMPA type subunit 2) Glutamate receptors are the predominant excitatory neurotransmitter receptors in the mammalian brain and are activated in a variety of normal neurophysiologic processes. This gene product belongs to a family of glutamate receptors that are sensitive to alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA), and function as ligand-activated cation channels. These channels are assembled from 4 related subunits, GRIA1-4. The subunit encoded by this gene (GRIA2) is subject to RNA editing (CAG->CGG; Q->R) within the second transmembrane domain, which is thought to render the channel impermeable to Ca(2+). Human and animal studies suggest that pre-mRNA editing is essential for brain function, and defective GRIA2 RNA editing at the Q/R site may be relevant to amyotrophic lateral sclerosis (ALS) etiology. Alternative splicing, resulting in transcript variants encoding different isoforms, (including the flip and flop isoforms that vary in their signal transduction properties), has been noted for this gene. [provided by RefSeq, Jul 2008]
GRIA2 Gene-Disease associations (from GenCC):
  • neurodevelopmental disorder with language impairment and behavioral abnormalities
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics, G2P, Illumina

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.304 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GRIA2NM_001083619.3 linkc.230-22302G>C intron_variant Intron 2 of 15 ENST00000264426.14 NP_001077088.2 P42262-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GRIA2ENST00000264426.14 linkc.230-22302G>C intron_variant Intron 2 of 15 1 NM_001083619.3 ENSP00000264426.9 P42262-1

Frequencies

GnomAD3 genomes
AF:
0.196
AC:
29807
AN:
151802
Hom.:
3339
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.309
Gnomad AMI
AF:
0.101
Gnomad AMR
AF:
0.150
Gnomad ASJ
AF:
0.140
Gnomad EAS
AF:
0.160
Gnomad SAS
AF:
0.0722
Gnomad FIN
AF:
0.165
Gnomad MID
AF:
0.0949
Gnomad NFE
AF:
0.160
Gnomad OTH
AF:
0.192
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.196
AC:
29851
AN:
151922
Hom.:
3350
Cov.:
31
AF XY:
0.194
AC XY:
14373
AN XY:
74244
show subpopulations
African (AFR)
AF:
0.309
AC:
12794
AN:
41422
American (AMR)
AF:
0.150
AC:
2287
AN:
15240
Ashkenazi Jewish (ASJ)
AF:
0.140
AC:
485
AN:
3466
East Asian (EAS)
AF:
0.159
AC:
816
AN:
5126
South Asian (SAS)
AF:
0.0727
AC:
350
AN:
4814
European-Finnish (FIN)
AF:
0.165
AC:
1747
AN:
10586
Middle Eastern (MID)
AF:
0.102
AC:
30
AN:
294
European-Non Finnish (NFE)
AF:
0.160
AC:
10841
AN:
67952
Other (OTH)
AF:
0.194
AC:
409
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1150
2299
3449
4598
5748
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
306
612
918
1224
1530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0655
Hom.:
68
Bravo
AF:
0.203
Asia WGS
AF:
0.142
AC:
494
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
1.0
DANN
Benign
0.23
PhyloP100
0.46
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10517665; hg19: chr4-158202402; API